ATMgerm line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies

MLA

Elitzur, Sarah, et al. “ATMgerm Line Pathogenic Variants Affect Outcomes in Children with Ataxia-Telangiectasia and Hematological Malignancies.” Blood, vol. 144, no. 11, Sept. 2024, pp. 1193–205. EBSCOhost, https://doi.org/10.1182/blood.2024024283.

APA

Elitzur, S., Shiloh, R., Loeffen, J. L. C., Pastorczak, A., Takagi, M., Bomken, S., Baruchel, A., Lehrnbecher, T., Tasian, S. K., Abla, O., Arad-Cohen, N., Astigarraga, I., Ben-Harosh, M., Bodmer, N., Brozou, T., Ceppi, F., Chugaeva, L., Dalla Pozza, L., Ducassou, S., … Borkhardt, A. (2024). ATMgerm line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies. Blood, 144(11), 1193–1205. https://doi.org/10.1182/blood.2024024283

Chicago

Elitzur, Sarah, Ruth Shiloh, Jan L. C. Loeffen, Agata Pastorczak, Masatoshi Takagi, Simon Bomken, Andre Baruchel, et al. 2024. “ATMgerm Line Pathogenic Variants Affect Outcomes in Children with Ataxia-Telangiectasia and Hematological Malignancies.” Blood 144 (11): 1193–1205. doi:10.1182/blood.2024024283.